semaglutide nursing implications side effects and management tips Semaglutide-Mediated Remodeling of Adipose Tissue

New Gallup data shows GLP-1 use has doubled nationwide as telehealth startups and investors are reshaping the weight-loss market.

The Europe Insulin Drugs And Glucagon-Like Peptide 1 (GLP-1) Receptor Agonist Market worth USD 10.49 billion in 2026 is growing at a CAGR of 4.27% to reach USD 12.93 billion by 2031

Daily Harvest's debut of its GLP-1 Companion Food Collection as part of its quick-to-prep January Jumpstart plan includes meals made with only real foods that are calorie-conscious while delivering ample vitamins and minerals, Carolina Schneider, MS, RD, Daily Harvests nutrition advisor, told FoodNavigator-USA.

A recent lawsuit alleges that semaglutide and similar medications in the same class may be linked to gastroparesis, a condition characterized by delayed stomach emptying that can have severe consequences for some.